These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31247346)

  • 1. Ultramorphological analysis of plaque advancement and cholesterol crystal formation in Ldlr knockout mouse atherosclerosis.
    Baumer Y; McCurdy S; Jin X; Weatherby TM; Dey AK; Mehta NN; Yap JK; Kruth HS; Boisvert WA
    Atherosclerosis; 2019 Aug; 287():100-111. PubMed ID: 31247346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice.
    Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP
    Circ Res; 2008 May; 102(10):1202-11. PubMed ID: 18451340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice.
    Kiouptsi K; Pontarollo G; Todorov H; Braun J; Jäckel S; Koeck T; Bayer F; Karwot C; Karpi A; Gerber S; Jansen Y; Wild P; Ruf W; Daiber A; Van Der Vorst E; Weber C; Döring Y; Reinhardt C
    Gut Microbes; 2020 Nov; 11(6):1809-1823. PubMed ID: 32579470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.
    Jones SM; Mann A; Conrad K; Saum K; Hall DE; McKinney LM; Robbins N; Thompson J; Peairs AD; Camerer E; Rayner KJ; Tranter M; Mackman N; Owens AP
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1271-1282. PubMed ID: 29599135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.
    Bode N; Grebe A; Kerksiek A; Lütjohann D; Werner N; Nickenig G; Latz E; Zimmer S
    Biochem Biophys Res Commun; 2016 Sep; 478(1):356-362. PubMed ID: 27416761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
    Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.
    Vengrenyuk Y; Nishi H; Long X; Ouimet M; Savji N; Martinez FO; Cassella CP; Moore KJ; Ramsey SA; Miano JM; Fisher EA
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):535-46. PubMed ID: 25573853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
    Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
    Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
    Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
    Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging.
    Lim RS; Suhalim JL; Miyazaki-Anzai S; Miyazaki M; Levi M; Potma EO; Tromberg BJ
    J Lipid Res; 2011 Dec; 52(12):2177-2186. PubMed ID: 21949051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma.
    Ho-Tin-Noé B; Vo S; Bayles R; Ferrière S; Ladjal H; Toumi S; Deschildre C; Ollivier V; Michel JB
    J Pathol; 2017 Apr; 241(5):671-682. PubMed ID: 28039859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling.
    Canfrán-Duque A; Rotllan N; Zhang X; Andrés-Blasco I; Thompson BM; Sun J; Price NL; Fernández-Fuertes M; Fowler JW; Gómez-Coronado D; Sessa WC; Giannarelli C; Schneider RJ; Tellides G; McDonald JG; Fernández-Hernando C; Suárez Y
    Circulation; 2023 Jan; 147(5):388-408. PubMed ID: 36416142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
    Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
    Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.
    Fotakis P; Kothari V; Thomas DG; Westerterp M; Molusky MM; Altin E; Abramowicz S; Wang N; He Y; Heinecke JW; Bornfeldt KE; Tall AR
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):e253-e272. PubMed ID: 31578081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.